Clinical Trial Update: Randomized Controlled Clinical Outcomes of the Vanguard XP Bicruciate Knee System [NA]

View source ↗

Summary

A terminated randomized trial update for the Vanguard XP Bicruciate Knee System with posted results, investigating knee arthroplasty outcomes in conditions rela…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoarthritis
• Rheumatoid Arthritis

Drugs mentioned

• Vanguard XP Bicruciate Knee System

Snippet

Sponsor: Zimmer Biomet | Conditions: Osteoarthritis, Rheumatoid Arthritis | NA | Status: TERMINATED | Results posted: 2023-02-21